Author: Ken Duenke

The National Cancer Institute (NCI), part of the National Institutes of Health, issued an announcement encouraging treatment with anticancer drugs via two methods, after surgery, for women with advanced ovarian cancer. The combined methods, which deliver drugs into a vein and directly into the abdomen, extend overall survival for women with advanced ovarian cancer by about a year. The Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital participated in the NCI-supported clinical trial which led to this clinical announcement.

The recent $2.5 million grant will support the creation of a permanent endowment for the center directed by Michael W. Sherraden.

The trustees also voted to approve amendments to the constitution and bylaws of the Faculty Senate, according to Chancellor Mark S. Wrighton.

A Dec. 9 performance of works from the Renaissance and American folk songs is dedicated in memory of Elizabeth Gray Danforth.

Known for pioneering research, Ellenberger comes to the University from Harvard Medical School; the appointment will become effective Jan. 1.

The Record will not be published again until Jan. 20. We hope you and your family have a wonderful holiday season and a happy new year.

Chenyang Lu, Ph.D., Weixong Zhang, Ph.D., Ervin Y. Rodin, Ph.D., R. Martin Arthur, Ph.D., Da-Ren Chen, Ph.D., and more…

Medical researchers have found that a protein known as MDC1 has a role in homologous recombination — a discovery that could be exploited. More medical news

Photo by Mary ButkusThe School of Law’s Stephen H. Legomsky visits with the School of Medicine’s Alison M. Goate at the Faculty Achievement Awards Ceremony.

Photo by Robert BostonThe Program in Occupational Therapy recently received a grant to provide exercise programs for people with mobility impairments.